Literature DB >> 19258308

Genomic analyses of musashi1 downstream targets show a strong association with cancer-related processes.

Raquel de Sousa Abreu1, Patricia C Sanchez-Diaz, Christine Vogel, Suzanne C Burns, Daijin Ko, Tarea L Burton, Dat T Vo, Soudhamini Chennasamudaram, Shu-Yun Le, Bruce A Shapiro, Luiz O F Penalva.   

Abstract

Musashi1 (Msi1) is a highly conserved RNA-binding protein with pivotal functions in stem cell maintenance, nervous system development, and tumorigenesis. Despite its importance, only three direct mRNA targets have been characterized so far: m-numb, CDKN1A, and c-mos. Msi1 has been shown to affect their translation by binding to short elements located in the 3'-untranslated region. To better understand Msi1 functions, we initially performed an RIP-Chip analysis in HEK293T cells; this method consists of isolation of specific RNA-protein complexes followed by identification of the RNA component via microarrays. A group of 64 mRNAs was found to be enriched in the Msi1-associated population compared with controls. These genes belong to two main functional categories pertinent to tumorigenesis: 1) cell cycle, cell proliferation, cell differentiation, and apoptosis and 2) protein modification (including ubiquitination and ubiquitin cycle). To corroborate our findings, we examined the impact of Msi1 expression on both mRNA (transcriptomic) and protein (proteomic) expression levels. Genes whose mRNA levels were affected by Msi1 expression have a Gene Ontology distribution similar to RIP-Chip results, reinforcing Msi1 participation in cancer-related processes. The proteomics study revealed that Msi1 can have either positive or negative effects on gene expression of its direct targets. In summary, our results indicate that Msi1 affects a network of genes and could function as a master regulator during development and tumor formation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19258308      PMCID: PMC2673281          DOI: 10.1074/jbc.M809605200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis.

Authors:  E Oda; R Ohki; H Murasawa; J Nemoto; T Shibue; T Yamashita; T Tokino; T Taniguchi; N Tanaka
Journal:  Science       Date:  2000-05-12       Impact factor: 47.728

2.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

3.  p14ARF links the tumour suppressors RB and p53.

Authors:  S Bates; A C Phillips; P A Clark; F Stott; G Peters; R L Ludwig; K H Vousden
Journal:  Nature       Date:  1998-09-10       Impact factor: 49.962

4.  RNA-binding protein Musashi family: roles for CNS stem cells and a subpopulation of ependymal cells revealed by targeted disruption and antisense ablation.

Authors:  Shin-ichi Sakakibara; Yuki Nakamura; Tetsu Yoshida; Shinsuke Shibata; Masato Koike; Hiroshi Takano; Shuichi Ueda; Yasuo Uchiyama; Tetsuo Noda; Hideyuki Okano
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-29       Impact factor: 11.205

5.  Biotinylated tags for recovery and characterization of ribonucleoprotein complexes.

Authors:  Luiz O F Penalva; Jack D Keene
Journal:  Biotechniques       Date:  2004-10       Impact factor: 1.993

6.  ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.

Authors:  Y Zhang; Y Xiong; W G Yarbrough
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

7.  The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.

Authors:  J Pomerantz; N Schreiber-Agus; N J Liégeois; A Silverman; L Alland; L Chin; J Potes; K Chen; I Orlow; H W Lee; C Cordon-Cardo; R A DePinho
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

8.  Mammary tumor induction in transgenic mice expressing an RNA-binding protein.

Authors:  Charles R Tessier; Glenn A Doyle; Brad A Clark; Henry C Pitot; Jeff Ross
Journal:  Cancer Res       Date:  2004-01-01       Impact factor: 12.701

9.  Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo.

Authors:  Sripathi M Sureban; Randal May; Robert J George; Brian K Dieckgraefe; Howard L McLeod; Satish Ramalingam; Kumar S Bishnupuri; Gopalan Natarajan; Shrikant Anant; Courtney W Houchen
Journal:  Gastroenterology       Date:  2008-03-04       Impact factor: 22.682

10.  Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.

Authors:  T Kamijo; J D Weber; G Zambetti; F Zindy; M F Roussel; C J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

View more
  49 in total

1.  Autoregulation of Musashi1 mRNA translation during Xenopus oocyte maturation.

Authors:  Karthik Arumugam; Melanie C Macnicol; Angus M Macnicol
Journal:  Mol Reprod Dev       Date:  2012-07-09       Impact factor: 2.609

Review 2.  Context-dependent regulation of Musashi-mediated mRNA translation and cell cycle regulation.

Authors:  Melanie C MacNicol; Chad E Cragle; Angus M MacNicol
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

3.  Suppression of intestinal tumorigenesis in Apc mutant mice upon Musashi-1 deletion.

Authors:  Andy R Wolfe; Amanda Ernlund; William McGuinness; Carl Lehmann; Kaitlyn Carl; Nicole Balmaceda; Kristi L Neufeld
Journal:  J Cell Sci       Date:  2017-01-12       Impact factor: 5.285

4.  The RNA-binding protein Musashi-1 regulates proteasome subunit expression in breast cancer- and glioma-initiating cells.

Authors:  Chann Lagadec; Erina Vlashi; Patricia Frohnen; Yazeed Alhiyari; Mabel Chan; Frank Pajonk
Journal:  Stem Cells       Date:  2014-01       Impact factor: 6.277

Review 5.  Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets.

Authors:  Alexander E Kudinov; John Karanicolas; Erica A Golemis; Yanis Boumber
Journal:  Clin Cancer Res       Date:  2017-01-31       Impact factor: 12.531

6.  Visual activity regulates neural progenitor cells in developing xenopus CNS through musashi1.

Authors:  Pranav Sharma; Hollis T Cline
Journal:  Neuron       Date:  2010-11-04       Impact factor: 17.173

7.  A conserved three-nucleotide core motif defines Musashi RNA binding specificity.

Authors:  N Ruth Zearfoss; Laura M Deveau; Carina C Clingman; Eric Schmidt; Emily S Johnson; Francesca Massi; Sean P Ryder
Journal:  J Biol Chem       Date:  2014-11-03       Impact factor: 5.157

8.  Data mining of functional RNA structures in genomic sequences.

Authors:  Shu-Yun Le; Bruce A Shapiro
Journal:  Wiley Interdiscip Rev Data Min Knowl Discov       Date:  2011-01-10

9.  RNA-binding protein PCBP2 modulates glioma growth by regulating FHL3.

Authors:  Wei Han; Zhongshuai Xin; Zhiqiang Zhao; Wen Bao; Xihua Lin; Bin Yin; Jizong Zhao; Jiangang Yuan; Boqin Qiang; Xiaozhong Peng
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

10.  Alternative polyadenylation in glioblastoma multiforme and changes in predicted RNA binding protein profiles.

Authors:  Jiaofang Shao; Jing Zhang; Zengming Zhang; Huawei Jiang; Xiaoyan Lou; Bingding Huang; Gregory Foltz; Qing Lan; Qiang Huang; Biaoyang Lin
Journal:  OMICS       Date:  2013-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.